Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products

Curr Drug Targets. 2014;15(10):973-81.

Abstract

The peptidyl prolyl cis/trans isomerase Pin1, the human ortholog of yeast Ess1 specifically isomerizes peptide bindings of pSer/pThr-Pro residues in various proteins, and regulates the expression levels and functions of phosphorylated proteins. Activation of Pin1 is associated with pathology of a variety of diseases, such as cancer, Alzheimer's disease, infectious diseases and so on. Therefore, regulatory compounds for Pin1 can be applied as a clinical medicine against these diseases. Many chemists have exerted themselves to synthesize the inhibitors based on the 3D structure of Pin1. We have screened for the inhibitors against Pin1 from the natural products including the functional foods. Here we review the Pin1-associated pathology and the known inhibitors identified from natural products. And we introduce the screening methods targeting Pin1 activity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / pathology
  • Animals
  • Biological Products / pharmacology*
  • Biological Products / therapeutic use
  • Enzyme Inhibitors / pharmacology*
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Immune System Diseases / drug therapy
  • Immune System Diseases / pathology
  • NIMA-Interacting Peptidylprolyl Isomerase
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Parkinson Disease / drug therapy
  • Parkinson Disease / pathology
  • Peptidylprolyl Isomerase / antagonists & inhibitors*
  • Peptidylprolyl Isomerase / chemistry
  • Peptidylprolyl Isomerase / metabolism*

Substances

  • Biological Products
  • Enzyme Inhibitors
  • NIMA-Interacting Peptidylprolyl Isomerase
  • PIN1 protein, human
  • Peptidylprolyl Isomerase